COVID Vaccines
Sort by:
Columbia University's Zuckerman Institute
COVID-19 saRNA Vaccine: Is It Possible That There Is a Cheaper and Faster Solution?
FEATURING
Robin J. Shattock
- 3,363 views
- August 24, 2020
- 12
American College of Cardiology
COVID-19 Vaccine Update: How Promising Are Preliminary mRNA Vaccine Results?
FEATURING
Kim Eagle
- 74 views
- September 10, 2020
- 1
UCSF School of Medicine
COVID-19 Vaccine September Update: What Are the Current Phase 3 Trial Candidates? Will We Have a Vaccine by October or November?
FEATURING
George Rutherford
- 4,039 views
- September 14, 2020
- 12
Columbia University's Zuckerman Institute
COVID-19 Vaccine Trials on 6 Continents: Which Eight Vaccine Candidates Enrolled in Phase 3 Trials?
FEATURING
Daniel Lucey
- 4,655 views
- September 16, 2020
- 11
Columbia University's Zuckerman Institute
Development of a DNA SARS-CoV-2 Vaccine: What Are the Advantages of DNA and RNA Approaches for Rapid Vaccine Deployment?
FEATURING
Ami Patel
- 2,638 views
- September 17, 2020
- 7
Michael S. Kinch
COVID-19 Vaccine (September Update): What Are the Biggest Concerns?
- 9,703 views
- September 22, 2020
- 59
Columbia University's Zuckerman Institute
COVID-19 Vaccine Trials Summary: Discussion and Q&A
FEATURING
Daniel Lucey
- 76 views
- September 22, 2020
- 1
Columbia University's Zuckerman Institute
COVID-19 Resilience Plan (October Update): Is the End of the Pandemic Before 2024 More and More Unlikely?
FEATURING
Irwin Redlener
- 6,474 views
- October 14, 2020
- 14
Amesh Adalja
COVID-19 Vaccine (October Update): What Kind of Vaccines Are in Phase 3 Trials? How Will the Vaccine Be Distributed?
- 19,155 views
- October 14, 2020
- 85
Arthur Caplan
COVID-19 Vaccine: What Does the Early Approval Mean in Practical Terms? Who Should Be First in Line for the Vaccine?
- 4,266 views
- October 16, 2020
- 20